Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Selenoprotein synthesis and side-effects of statins.

Moosmann B, Behl C.

Lancet. 2004 Mar 13;363(9412):892-4. Review.

PMID:
15031036
2.

Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway.

Moosmann B, Behl C.

Trends Cardiovasc Med. 2004 Oct;14(7):273-81. Review.

PMID:
15542379
3.

Autoimmune disease and other potential side-effects of statins.

Noël B.

Lancet. 2004 Jun 12;363(9425):2000. No abstract available.

PMID:
15194268
4.

Statin-induced myopathies.

Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ.

Pharmacol Rep. 2011;63(4):859-66. Review.

5.

Adverse effects of statins - mechanisms and consequences.

Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A.

Curr Drug Saf. 2009 Sep;4(3):209-28. Epub 2009 Sep 1. Review.

PMID:
19534648
6.

The myopathy of statins.

Smogorzewski M.

J Ren Nutr. 2005 Jan;15(1):87-93. Review.

PMID:
15648014
7.

Statin-induced apoptosis and skeletal myopathy.

Dirks AJ, Jones KM.

Am J Physiol Cell Physiol. 2006 Dec;291(6):C1208-12. Epub 2006 Aug 2. Review.

8.

[Prevention of coronary heart disease with statins. Which patients profit?].

Adam O, Forth W.

MMW Fortschr Med. 2003 Jun 19;145(25):37-40. German.

PMID:
12891851
9.

Statins and myotoxicity: a therapeutic limitation.

Tiwari A, Bansal V, Chugh A, Mookhtiar K.

Expert Opin Drug Saf. 2006 Sep;5(5):651-66. Review.

PMID:
16907655
10.

The safety of statins in clinical practice.

Armitage J.

Lancet. 2007 Nov 24;370(9601):1781-90. Review.

PMID:
17559928
11.

[Muscle-related adverse effects of statins].

Pohjola-Sintonen S, Julkunen H.

Duodecim. 2014;130(16):1622-7. Review. Finnish.

PMID:
25269368
12.

[Current views on lipid metabolism: statin-induced myopathy].

Teichmann LL, Fleck M.

Z Rheumatol. 2010 Oct;69(8):696-8, 700-1. doi: 10.1007/s00393-009-0584-6. German.

PMID:
20862481
13.

Safety considerations for statins.

Bolego C, Baetta R, Bellosta S, Corsini A, Paoletti R.

Curr Opin Lipidol. 2002 Dec;13(6):637-44. Review.

PMID:
12441888
14.

Adverse effects of statins - myths and reality.

Šimić I, Reiner Ž.

Curr Pharm Des. 2015;21(9):1220-6. Review.

PMID:
25312733
15.

[Transplant coronary artery disease--treatment with statins].

Wolszakiewicz J, Bilińska M.

Pol Merkur Lekarski. 2004 May;16(95):472-3. Review. Polish.

PMID:
15518430
16.

[Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].

Huić M, Anić B, Cikes N, Bosnić D, Sentić M, Markeljević J, Mayer M, Pazanin L.

Lijec Vjesn. 2002 Mar-Apr;124(3-4):73-6. Croatian.

PMID:
18956824
17.

Coenzyme Q(10) and statin myalgia: what is the evidence?

Mas E, Mori TA.

Curr Atheroscler Rep. 2010 Nov;12(6):407-13. doi: 10.1007/s11883-010-0134-3.

PMID:
20725809
18.

Phenotype standardization for statin-induced myotoxicity.

Alfirevic A, Neely D, Armitage J, Chinoy H, Cooper RG, Laaksonen R, Carr DF, Bloch KM, Fahy J, Hanson A, Yue QY, Wadelius M, Maitland-van Der Zee AH, Voora D, Psaty BM, Palmer CN, Pirmohamed M.

Clin Pharmacol Ther. 2014 Oct;96(4):470-6. doi: 10.1038/clpt.2014.121. Epub 2014 Jun 4.

19.

Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNA.

Moustafa ME, Carlson BA, El-Saadani MA, Kryukov GV, Sun QA, Harney JW, Hill KE, Combs GF, Feigenbaum L, Mansur DB, Burk RF, Berry MJ, Diamond AM, Lee BJ, Gladyshev VN, Hatfield DL.

Mol Cell Biol. 2001 Jun;21(11):3840-52.

20.

[Myotoxicity and rhabdomyolisis due to statins].

Banga JD.

Ned Tijdschr Geneeskd. 2001 Dec 8;145(49):2371-6. Review. Dutch.

PMID:
11770264

Supplemental Content

Support Center